Pfizer CEO Albert Bourla receives honorary doctorate from Technion

Bourla was recognized for his exceptional leadership in developing the first safe and effective COVID-19 vaccine, which remains the gold standard for vaccines against the novel coronavirus.

New study determines ideal COVID-19 vaccine type and timing during pregnancy

Researchers say the findings can help doctors council pregnant women on which trimester is best to receive a COVID vaccine.

COVID-19: Aid for Omicron-impacted businesses approved by Knesset

The amount of the grant will change depending on the turnover of the business in a base year.

Does Psalm 91 contain a remedy for COVID-19?

The Jewish response to the coronavirus pandemic was largely traditional: fasting and repentance, prayer and Psalms, especially Psalm 91 (Yoshev B’Seter).

COVID-19: Vaccine recommended by committee for children 6 months-5 years

The Pandemic Response Committee recommended that children in Israel between the ages of 6 months and five years may soon be eligible to receive a COVID-19 vaccine.

Llama lying down

Llama nanobodies could be used to develop COVID-19 treatment - study

The study found that nanobodies derived from a llama could be used to develop an inhalable spray to combat COVID-19 and other viral diseases.

EU chief can't find texts with Pfizer chief on COVID-19 vaccine deal

European Commission president Ursula von der Leyen exchanged texts with Pfizer chief Albert Bourla for a month when they were negotiating a massive vaccine contract.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy